ViroGates A/S (CPH:VIRO)
9.92
-0.13 (-1.29%)
Sep 17, 2025, 4:21 PM CET
ViroGates Revenue
ViroGates had revenue of 3.67M DKK in the quarter ending June 30, 2025, with 240.07% growth. This brings the company's revenue in the last twelve months to 9.40M, up 36.13% year-over-year. In the year 2024, ViroGates had annual revenue of 7.14M with 2.22% growth.
Revenue (ttm)
9.40M
Revenue Growth
+36.13%
P/S Ratio
8.16
Revenue / Employee
1.34M
Employees
10
Market Cap
76.73M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7.14M | 155.00K | 2.22% |
Dec 31, 2023 | 6.99M | -8.21M | -54.02% |
Dec 31, 2022 | 15.20M | 6.95M | 84.27% |
Dec 31, 2021 | 8.25M | 2.89M | 54.03% |
Dec 31, 2020 | 5.35M | 1.77M | 49.47% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk | 311.94B |
Coloplast | 27.87B |
Genmab | 23.16B |
Demant | 22.59B |
ALK-Abelló | 5.86B |
H. Lundbeck | 23.52B |
Zealand Pharma | 9.11B |
Ambu A/S | 5.96B |